BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35262503)

  • 1. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With Breast Cancer: Retrospective Study.
    Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
    J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
    Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
    Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
    Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
    Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients.
    Hueting TA; van Maaren MC; Hendriks MP; Koffijberg H; Siesling S
    Breast; 2023 Jun; 69():382-391. PubMed ID: 37087910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.
    Xiao J; Mo M; Wang Z; Zhou C; Shen J; Yuan J; He Y; Zheng Y
    JMIR Med Inform; 2022 Feb; 10(2):e33440. PubMed ID: 35179504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
    Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
    World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and validation of risk prediction model for new-onset cardiovascular diseases among breast cancer patients: Based on regional medical data of Inner Mongolia].
    Zhang YJ; Qiao LY; Qi M; Yan Y; Kang WW; Liu GZ; Wang MY; Xi YF; Wang SF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):471-479. PubMed ID: 37291923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
    Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
    Clin Orthop Relat Res; 2023 Jun; 482(1):143-57. PubMed ID: 37306629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
    Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
    Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.